BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29390104)

  • 1. Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
    Mosher CA; Brown GR; Weideman RA; Crook TW; Cipher DJ; Spechler SJ; Feagins LA
    Inflamm Bowel Dis; 2018 Feb; 24(3):617-623. PubMed ID: 29390104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
    J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
    Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
    Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
    Taylor CC; Millien VO; Hou JK; Massarweh NN
    J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
    Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, management, and course of cancer in patients with inflammatory bowel disease.
    Algaba A; Guerra I; Marín-Jiménez I; Quintanilla E; López-Serrano P; García-Sánchez MC; Casis B; Taxonera C; Moral I; Chaparro M; Martín-Rodríguez D; Martín-Arranz MD; Manceñido N; Menchén L; López-Sanromán A; Castaño Á; Bermejo F
    J Crohns Colitis; 2015 Apr; 9(4):326-33. PubMed ID: 25687203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.
    Söderlund S; Brandt L; Lapidus A; Karlén P; Broström O; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2009 May; 136(5):1561-7; quiz 1818-9. PubMed ID: 19422077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Malignant Cancers in Inflammatory Bowel Disease.
    Loo SY; Vutcovici M; Bitton A; Lakatos PL; Azoulay L; Suissa S; Brassard P
    J Crohns Colitis; 2019 Sep; 13(10):1302-1310. PubMed ID: 30874294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family history as a risk factor for colorectal cancer in inflammatory bowel disease.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Gastroenterology; 2001 May; 120(6):1356-62. PubMed ID: 11313305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Madanchi M; Zeitz J; Barthel C; Samaras P; Scharl S; Sulz MC; Biedermann L; Frei P; Vavricka SR; Rogler G; Scharl M
    Digestion; 2016; 94(1):1-8. PubMed ID: 27318857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.